Luncheon Symposium 1 
Deep Healing, Real Results: Redefining Success in Mild-to-Moderate UC
|
Room B |
| Date & Time
|
June 25 (Thu), 12:30-13:10 |
| Chair(s) |
Xiang Gao (Sun Yat-sen University, China)
Eun Young Kim (Daegu Catholic University, Korea) |
| Speaker(s) |
12:30-12:50 |
From Endoscopic to Histological Healing: Can We Target Deeper with Optimized Mesalamine Therapy?
Fernando Magro (University of Porto, Portugal) |
| 12:50-13:10 |
The Power of Optimization – Implementation in Clinical Practice
Sung Wook Hwang (University of Ulsan, Korea) |
Breakfast with Master 1 
Beyond the Clinical Trial Data : Impact of Real-World Experience of ZEPOSIA®
|
Room B |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Hyun Soo Kim (Chonnam National University, Korea) |
| Speaker(s) |
07:30-08:00 |
Refining Evidence-Based Strategies in UC Practice: Positioning Ozanimod Based on Real-World Experience in Korea
Dong Hyun Kim (Chonnam National University, Korea) |
Breakfast with Master 2 
Sequential Treatment in Ulcerative Colitis
|
Room C |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Sang Wook Kim (Jeonbuk National University, Korea) |
| Speaker(s) |
07:30-08:00 |
The Current Role of Filgotinib in Ulcerative Colitis
Fumihito Hirai (Fukuoka University, Japan) |
Breakfast with Master 3 
Start Strong in Ulcerative Colitis with Upadacitinib
|
Room D |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Geom-Seog Seo (Wonkwang University, Korea) |
| Speaker(s) |
07:30-07:45 |
When Time Matters in Ulcerative Colitis: Upadacitinib for Urgent Disease Control
Dong Hoon Baek (Pusan National University, Korea) |
| 07:45-08:00 |
Connecting the Dots: Evidence to Insight with Upadacitinib
Sang-Bum Kang (The Catholic University of Korea, Korea) |
Breakfast with Master 4 
Transforming Bowel Preparation Strategies in IBD: A Change in Perspective Toward Mini Oral Sulfate Tablets
|
Room E |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Jae Myung Cha (Kyung Hee University, Korea) |
| Speaker(s) |
07:30-08:00 |
Transforming Bowel Preparation Strategies in IBD: A Change in Perspective Toward Mini Oral Sulfate Tablets
Jaeseung Soh (Hallym University, Korea) |
Breakfast with Master 5 
New and Now: Introducing Etrasimod in Ulcerative Colitis
|
Room F |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Jae Hee Cheon (Yonsei University, Korea) |
| Speaker(s) |
07:30-08:00 |
Etrasimod in Ulcerative Colitis: Clinical Evidence and Its Role in Therapy
David T. Rubin (University of Chicago, USA) |
Luncheon Symposium 2 
Beyond Similarity: Clinical and Real-World Insights into Ustekinumab Biosimilars
|
Room B |
| Date & Time
|
June 26 (Fri), 12:20-13:00 |
| Chair(s) |
Katsuyoshi Matsuoka (Toho University, Japan)
Jonghun Lee (Dong-A University, Korea) |
| Speaker(s) |
12:20-12:40 |
What is Same and Different? : Clinical Value of Ustekinumab Biosimilar
Eun Soo Kim (Kyungpook National University, Korea) |
| 12:40-13:00 |
From Evidence to Experience: Real-World Application of Ustekinumab Biosimilar in Inflammatory Bowel Disease
Sang Hyoung Park (University of Ulsan, Korea) |
Luncheon Symposium 3 
Evolving IBD Care in the Era of IL-23 Inhibitor
|
Room C |
| Date & Time
|
June 26 (Fri), 12:20-13:00 |
| Chair(s) |
Masayuki Saruta (Jikei University, Japan)
Young-Ho Kim (Sungkyunkwan University, Korea) |
| Speaker(s) |
12:20-12:35 |
Unmet Needs in Korean IBD Care: Evolving Expectations for New Therapeutic Options
Seong-Joon Koh (Seoul National University, Korea) |
| 12:35-13:00 |
Advancing IBD Care with Guselkumab: Insights from Clinical and Real World Evidence
David T. Rubin (University of Chicago, USA) |
|
Luncheon Symposium 4
Fast-Acting, Long-Lasting Control: Upadacitinib in IBD
|
Room B |
| Date & Time
|
June 26 (Fri), 13:00-13:40 |
| Chair(s) |
Zhihua Ran (Shanghai University, China)
Sung-Ae Jung (Ewha Womans University, Korea) |
| Speaker(s) |
13:00-13:20 |
Optimizing Treatment Strategies in Ulcerative Colitis with Upadacitinib
Byong Duk Ye (University of Ulsan, Korea) |
| 13:20-13:40 |
Shaping a New Paradigm in Crohn’s Disease Management: The Role of Upadacitinib
Edward V. Loftus Jr. (Mayo Clinic College of Medicine and Science, USA) |
Luncheon Symposium 5 
A New Era in IBD Treatment: Optimizing Infliximab Therapy
|
Room C |
| Date & Time
|
June 26 (Fri), 13:00-13:40 |
| Chair(s) |
Zhanju Liu (Tongji University, China)
Yoon Tae Jeen (Korea University, Korea) |
| Speaker(s) |
13:00-13:20 |
Real-World Experience with Subcutaneous Infliximab: Updated Global Evidence
Silvio Danese (University Vita-Salute San Raffaele, Italy) |
| 13:20-13:40 |
Personalizing IBD Treatment: The Role of Therapeutic Drug Monitoring in Infliximab Therapy
Sung Noh Hong (Sungkyunkwan University, Korea) |
|
Meet the Expert 1
Advancing IBD Care with Subcutaneous Infliximab
|
Exhibition |
| Date & Time
|
June 26 (Fri), 15:50-16:20 |
| Speaker(s) |
15:50-16:20 |
Redefining IBD Treatment Strategies: The Role of Subcutaneous Infliximab
Rupert Leong (University of Sydney, Australia) |
|
Meet the Expert 2
Emerging Treatment in Crohn’s Disease with Fistula
|
Exhibition |
| Date & Time
|
June 26 (Fri), 15:50-16:20 |
| Speaker(s) |
15:50-16:20 |
Clinical Efficacy and Real World Experience with Guselkumab in CD with Fistula
Vipul Jairath (Western University, Canada) |
Breakfast with Master 6 
A Deep Dive into Shingles Prevention for IBD Patients
|
Room B |
| Date & Time
|
June 27 (Sat), 07:30-08:00 |
| Chair(s) |
Chang Hwan Choi (Chung-Ang University, Korea) |
| Speaker(s) |
07:30-08:00 |
A Deep Dive into Shingles Prevention for IBD Patients
Soo Jung Park (Yonsei University, Korea) |
Breakfast with Master 7 
Advancing the Standard of Care in Ulcerative Colitis: Safety‑Driven and Patient‑Centered Strategies
|
Room C |
| Date & Time
|
June 27 (Sat), 07:30-08:00 |
| Chair(s) |
Taeoh Kim (Inje University, Korea) |
| Speaker(s) |
07:30-08:00 |
Optimizing UC Management with Tofacitinib (Xeljanz): Updated Safety Data and Practical Vaccine Checklist for IBD Patients
Yu Kyung Jun (Seoul National University, Korea) |
|
Breakfast with Master 8
Beyond Similarity: Decision Pathways in IBD Biosimilars
|
Room D |
| Date & Time
|
June 27 (Sat), 07:30-08:00 |
| Chair(s) |
Kyu Chan Huh (Konyang University, Korea) |
| Speaker(s) |
07:30-08:00 |
The Role of Biosimilars in IBD : Guideline and Decision Insights
Shin Ju Oh (Kyung Hee University, Korea) |
Breakfast with Master 9 
Shifting Paradigms in Bowel Preparation: From Volume to Value
|
Room E |
| Date & Time
|
June 27 (Sat), 07:30-08:00 |
| Chair(s) |
Seunja Park (Kosin University, Korea) |
| Speaker(s) |
07:30-08:00 |
Differential clinical conveniences of OST; Orafang, The First Mover
Eun Ran Kim (Sungkyunkwan University, Korea) |
Luncheon Symposium 6 
Redefining Treatment Targets in IBD: From Disease Clearance to Transmural Healing
|
Room B |
| Date & Time
|
June 27 (Sat), 11:50-12:30 |
| Chair(s) |
Siddharth Singh (Mayo Clinic Arizona, USA)
Byung Ik Jang (Yeungnam University, Korea) |
| Speaker(s) |
11:50-12:10 |
Redefining UC Treatment Goals: Disease Clearance Insights from VERDICT
Vipul Jairath (Western University, Canada) |
| 12:10-12:30 |
Transmural Healing as a Treatment Target in CD: Vedolizumab Insights from VECTORS
Jun Lee (Chosun University, Korea) |
Luncheon Symposium 7 
Improving Bowel Preparation: From Better Results to Greater Convenience
|
Room C |
| Date & Time
|
June 27 (Sat), 11:50-12:30 |
| Chair(s) |
Chao-Hung Kuo (Kaohsiung University, Taiwan)
Dong Il Park (Sungkyunkwan University, Korea) |
| Speaker(s) |
11:50-12:10 |
Efficacy and Safety of DWJ1609 (CLEANCOL): A New 20-Tablet Oral Sulfate Solution for Bowel Preparation
Sung Hoon Jung (The Catholic University of Korea, Korea) |
| 12:10-12:30 |
Clinical Benefits of DWJ1609 (CLEANCOL): Enhancing Patient Compliance with Reduced Pill Burden
Subum Park (Pusan National University, Korea) |
